| 1 |
33603735 | O-Linked N-Acetylglucosamine Modification of Mitochondrial Antiviral Signaling Protein Regulates Antiviral Signaling by Modulating Its Activity. | 2020 |
1 |
| 2 |
29431732 | STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells. | 2018 Mar 1 |
1 |
| 3 |
27426928 | Molecular cloning and functional characterization of porcine E74-like factor 4 (ELF4). | 2016 Dec |
1 |
| 4 |
24531619 | Death-associated protein kinase 1 is an IRF3/7-interacting protein that is involved in the cellular antiviral immune response. | 2014 May |
1 |
| 5 |
21478011 | Type I interferons as radiosensitisers for pancreatic cancer. | 2011 Sep |
1 |
| 6 |
20406818 | Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. | 2010 Jun 25 |
2 |
| 7 |
15728510 | The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1. | 2005 Mar 1 |
1 |
| 8 |
15752772 | Intracellular interferon triggers Jak/Stat signaling cascade and induces p53-dependent antiviral protection. | 2005 Apr 15 |
1 |
| 9 |
16226271 | Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta. | 2005 Nov 30 |
3 |
| 10 |
12759354 | Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. | 2003 Jul 25 |
1 |
| 11 |
11846976 | On the role of IRF in host defense. | 2002 Jan |
1 |
| 12 |
11884587 | Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis. | 2002 Apr |
2 |
| 13 |
11955727 | A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04). | 2002 Apr 1 |
1 |
| 14 |
12068083 | Interferon-beta activates multiple signaling cascades in primary human microglia. | 2002 Jun |
1 |
| 15 |
10918594 | IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. | 2000 Jul 13 |
2 |
| 16 |
10363567 | Radiosensitizing effect of natural and recombinant beta-interferons in a human lung carcinoma in vitro. | 1999 |
1 |
| 17 |
9815298 | Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma. | 1998 Sep-Oct |
3 |
| 18 |
21533466 | Mechanisms of resistance off NSCLC to interferons. | 1997 May |
1 |
| 19 |
8892645 | In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. | 1996 Nov 1 |
2 |
| 20 |
7553067 | In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients. | 1995 Feb |
2 |
| 21 |
7523670 | Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells. | 1994 Jun |
1 |
| 22 |
8069001 | Interferon beta for multiple sclerosis. | 1994 May |
5 |
| 23 |
8301155 | Effects of cytokines on the pituitary-adrenal axis in cancer patients. | 1993 Oct |
2 |
| 24 |
8483840 | Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin. | 1993 Apr |
3 |
| 25 |
1289413 | Phase II trials of interferons-alpha and -beta in advanced sarcomas. | 1992 Dec |
2 |
| 26 |
1525120 | The effect of interferon on the metabolism of LDLs. | 1992 Sep |
2 |
| 27 |
1708891 | Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping. | 1991 May 1 |
1 |
| 28 |
1895445 | Effects of interferon beta ser and transforming growth factor beta on prostatic cell lines. | 1991 Oct |
3 |
| 29 |
1907881 | Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons. | 1991 Aug 15 |
1 |
| 30 |
1698636 | Immunochemical characterization of antigenic domains on human interferon-beta: spatially distinct epitopes are associated with both antiviral and antiproliferative activities. | 1990 Sep |
2 |
| 31 |
2082958 | A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma. | 1990 Aug |
1 |
| 32 |
2086672 | Biological and clinical effects of interferon-beta ser at two doses. | 1990 Dec |
2 |
| 33 |
2120284 | A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans. | 1990 Oct |
3 |
| 34 |
2136700 | Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells. | 1990 Jan 1 |
15 |
| 35 |
2140395 | Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity. | 1990 Apr |
1 |
| 36 |
2273299 | Phase II evaluation of recombinant interferon-beta (IFN-beta ser) in patients with diffuse mesothelioma: a Southwest Oncology Group study. | 1990 Oct |
1 |
| 37 |
2395002 | Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle. | 1990 Aug |
6 |
| 38 |
2472488 | Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine. | 1989 Jul 19 |
1 |
| 39 |
2514233 | Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT. | 1989 Dec |
1 |
| 40 |
2624146 | Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures. | 1989 Jul-Sep |
1 |
| 41 |
2785576 | Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta Ser. | 1989 Apr |
3 |
| 42 |
2809278 | Evaluation of neutralizing antibodies in patients treated with recombinant interferon-beta ser. | 1989 Sep |
1 |
| 43 |
2839097 | Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons. | 1988 May-Jun |
3 |
| 44 |
3045221 | Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial. | 1988 Jun |
3 |
| 45 |
3171246 | The long-term stability of recombinant (serine-17) human interferon-beta. | 1988 Aug |
3 |
| 46 |
3230332 | Effect of recombinant interferon-beta ser on primary human tumor colony-forming units. | 1988 Dec |
1 |
| 47 |
2957045 | Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro. | 1987 Sep 1 |
8 |
| 48 |
2960673 | Binding of recombinant-produced interferon beta ser to human lymphoblastoid cells. Evidence for two binding domains. | 1987 Nov 25 |
9 |
| 49 |
3039014 | Potency stability of recombinant (Serine-17) human interferon-beta. | 1987 Apr |
2 |
| 50 |
3079540 | Plasma lipoprotein changes in humans induced by beta-interferon. | 1987 Oct |
3 |